In this post in the Global Health Technologies Coalition’s (GHTC) “Breakthroughs” blog, Mandy Goldberg, global health research and development (R&D) advocacy intern at Research!America, shares the organization’s findings about the state of New Jersey from an analysis conducted in target states to measure the health and economic impact of global health R&D in the U.S. “Despite ranking eleventh in population size, New Jersey ranks third in R&D investment among states, thanks mainly to robust private-sector investment,” she writes, adding, “R&D spending in New Jersey increased by 11.4 percent in 2010, and global R&D spending was up by $1.4 billion, according to a 2011 report by the Healthcare Institute of New Jersey, implying even more future economic benefits for the state” (Halnon, 2/21).